Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Q1 2024 Earnings Call Transcript May 6, 2024 Corvus Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...
Results that may be inaccessible to you are currently showing.